Adverum Biotechnologies ADVM
$ 4.7
0.0%
Quarterly report 2024-Q3
added 11-04-2024
Adverum Biotechnologies General and Administrative Expenses 2011-2024 | ADVM
Annual General and Administrative Expenses Adverum Biotechnologies
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
49.9 M | 57.9 M | 64.4 M | 44.6 M | 28.4 M | 24.6 M | 20.9 M | 24.4 M | 22.1 M | 8 M | 1.78 M | 536 K | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
64.4 M | 536 K | 29 M |
Quarterly General and Administrative Expenses Adverum Biotechnologies
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9.78 M | 3.78 M | 11.4 M | 13.8 M | 12.5 M | 12.8 M | - | 17.2 M | 13.8 M | 15.2 M | - | 14.5 M | 21.9 M | 16.2 M | - | 11.4 M | 10.6 M | 9.04 M | - | 7.39 M | 7.13 M | 5.58 M | - | 4.83 M | 9.18 M | 5.37 M | - | 4.76 M | 4.06 M | 7.99 M | - | 6.15 M | 5.11 M | 8.32 M | - | 7.63 M | 4.96 M | 4.14 M | - | 2.4 M | 1.49 M | 726 K | - | 258 K | 194 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
21.9 M | 194 K | 8.32 M |